Superworth

Lemaitre Vascular price to book ratio LMAT

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
4.6×
10-year median
5.1×
Against its 10-year history
40th
percentile: 0 is its lowest day, 100 its highest
10-year range
0.4× to 7.5×
Peer median
4.3×

Lemaitre Vascular's price to book ratio is 4.6× as of Oct 23, 2026.

That is below its ten-year median of 5.1×, close to the middle of its last ten years.

Over that time it ranged from 0.4× in Mar 2020 to 7.5× in Oct 2017.

The median for 10 medical instruments and supplies stocks of a similar size is 4.3×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far4.6×4.3×6.6×
20255.0×5.0×6.8×
20246.3×4.2×7.3×
20234.4×3.7×5.6×
20223.9×3.6×4.7×
20214.4×4.1×7.4×
20205.1×0.4×5.1×
20190.5×0.5×5.1×
20183.7×3.5×7.1×
20175.8×4.8×7.5×
20165.4×3.1×5.4×
20154.2×2.0×4.2×
20142.0×1.7×2.3×
20132.3×1.7×2.4×
20121.7×1.5×1.9×
20111.7×1.6×2.1×

Against its peers

Companies in Medical - Instruments & Supplies nearest Lemaitre Vascular's size, closest first, today.

CompanyPrice to book ratio
LMATLemaitre Vascular4.6×
INSPInspire Medical Systems2.5×
UFPTUFP Technologies5.0×
EYENational Vision1.6×
CDRECadre3.7×
BVSBioventus5.5×
ATRCAtriCure5.8×
WRBYWarby Parker8.2×
STAAStaar Surgical3.1×
IRMDIradimed10.8×
NVSTEnvista1.2×
Peer median4.3×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Lemaitre Vascular

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.